Fiche centre
Washington University
St Louis — United States
Essais liés23clinical trials
VilleSt Louislocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04428476
Essais cliniques associés
23| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Eteplirsen | Myopathies | À vérifier | NCT06606340 | EVOLVE — A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice | ENROLLING_BY_INVITATION |
| [O-15]-Water PET Myocardial Perfusion Imaging (MPI) | Maladie coronarienne | Phase 3 | NCT05134012 | RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) | COMPLETED |
| RapidPulseTM Aspiration System | Accident vasculaire cérébral | Non applicable | NCT06029491 | TURBO — Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions | RECRUITING |
| VS-041 | Insuffisance cardiaque | Phase 1 | NCT07219511 | A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) | ACTIVE_NOT_RECRUITING |
| VS-7375 | Cancer | Phase 2 | NCT07659795 | TARGET-D 203 — A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer | RECRUITING |
| ONC206 | Cancer | Phase 2 | NCT07282587 | Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma | RECRUITING |
| Deramiocel (CAP-1002) | Myopathies | Phase 2 | NCT04428476 | HOPE-2-OLE — Open-label Extension of the HOPE-2 Trial | ACTIVE_NOT_RECRUITING |
| Ocrelizumab | SEP | À vérifier | NCT02807285 | Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis | NO_LONGER_AVAILABLE |
| Ocrelizumab | SEP | Phase 3 | NCT05123703 | Operetta 2 — A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) | ACTIVE_NOT_RECRUITING |
| Previous receipt of the Minder System (implantable continuous electroencephalographic (EEG) monitoring (iCEM) system) | Épilepsie | À vérifier | NCT07110454 | DETECT LTFU — Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up | RECRUITING |
| Receipt of the Minder System (implantable sub-scalp continuous electroencephalographic (EEG) monitoring (iCEM) system) | Épilepsie | Non applicable | NCT07110337 | DETECT — Diagnosing Epilepsy To EffeCT Change | RECRUITING |
| Adalimumab | Parkinson | Phase 2 | NCT06996652 | PRISMS — An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD) | RECRUITING |
| ASSESS ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | NCT06578195 | ASSESS ALL ALS Study | RECRUITING |
| PREVENT ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | NCT06581861 | PREVENT ALL ALS Study | RECRUITING |
| nL-TARDB-006 | Sclérose latérale amyotrophique | Phase 1/2 | NCT07743268 | Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS | ENROLLING_BY_INVITATION |
| COYA 302 | Sclérose latérale amyotrophique | Phase 2/3 | NCT07161999 | ALSTARS — Study of COYA 302 for the Treatment of ALS | ACTIVE_NOT_RECRUITING |
| Pridopidine | Sclérose latérale amyotrophique | Phase 3 | NCT07322003 | PREVAiLS — Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | RECRUITING |
| SAT-3247 | Myopathies | Phase 2 | NCT07287189 | BASECAMP — Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients | ACTIVE_NOT_RECRUITING |
| delpacibart zotadirsen | Myopathies | À vérifier | NCT07250737 | Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping | AVAILABLE |
| Ocrelizumab | SEP | Phase 3 | NCT05269004 | OLERO — A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| Anti-hypertensive therapy | Hypertension | Phase 4 | NCT02299414 | Chronic Hypertension and Pregnancy (CHAP) Project | COMPLETED |
| Celecoxib | Sclérose latérale amyotrophique | Phase 2 | NCT00355576 | Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis | COMPLETED |
| Fenebrutinib | SEP | Phase 3 | NCT04544449 | FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING |